Isotroin (Isotretinoin)

Isotretinoin binds to retinoic acid receptors in skin cells, shrinking sebaceous glands, lowering sebum output, normalizing follicular keratinization, and reducing inflammation. These actions address the core mechanisms that drive severe acne formation.

The dosage of Isotroin is individualized by the prescribing dermatologist based on the patient’s weight, severity of acne, and laboratory parameters. Only a qualified healthcare professional can determine the appropriate regimen.

Isotretinoin is classified as pregnancy category X because it is highly teratogenic. It must not be used by pregnant women or women who may become pregnant. Breastfeeding is also contraindicated, as the drug can be excreted in milk and affect the infant.

To order Isotroin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Compared with antibiotics or topical retinoids, isotretinoin offers a systemic approach that can achieve long‑lasting remission after a finite course. It is more potent for severe nodular or cystic acne but carries a higher risk profile, requiring careful monitoring and strict contraception.

Isotroin should be stored below 25 °C in its original container, protected from moisture and direct light. Keep the product out of reach of children and avoid exposing it to extreme temperatures or humidity.

Isotroin is taken orally, usually as a capsule, with a full glass of water. It is typically taken with food to reduce gastrointestinal discomfort, but the exact timing and dosing schedule are determined by the prescribing clinician.

The most serious risks include teratogenicity, severe depression or suicidal thoughts, inflammatory bowel disease exacerbation, significant liver enzyme elevation, hypertriglyceridemia, and pseudotumor cerebri. Patients should be monitored closely for any of these adverse events.

Isotroin should not be used by pregnant women, women planning pregnancy, or those who cannot commit to effective contraception. It is also contraindicated in patients with pre‑existing liver disease, uncontrolled hyperlipidaemia, or a history of severe psychiatric disorders without specialist oversight.